New molecular test aims to sharpen kidney transplant rejection diagnosis
NCT ID NCT07347353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a molecular test called HistoMx can help doctors better diagnose kidney transplant rejection in everyday practice. Researchers followed 400 kidney transplant recipients to see how often the test was used and whether it improved patient outcomes. The goal was to understand the real-world value of adding this test to standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAFT REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Paris Bichat university hospital
Paris, France
-
Paris Saint Louis University hospital
Paris, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI may spot hidden kidney transplant rejection
- Protein fingerprints may spot hidden transplant rejection
- Lung transplant moms: does Baby's DNA raise rejection risk?
- Stem cell trick may let kidney patients ditch daily pills
- Gene clues may explain why light therapy helps some transplant patients
- Tiny RNA clues could help kids avoid heart transplant complications